Holen Sie sich die Stockscreener-App
9.24
1.99%
0.18
Schlusskurs vom Vortag:
$9.06
Offen:
$9.18
24-Stunden-Volumen:
701.50K
Relative Volume:
0.59
Marktkapitalisierung:
$559.85M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-0.7113
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
+6.21%
1M Leistung:
-3.35%
6M Leistung:
-16.53%
1J Leistung:
-16.83%
1-Tages-Spanne:
$9.12
$9.44
1-Wochen-Bereich:
$8.36
$9.75
52-Wochen-Spanne:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
9.24 | 548.95M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Why hedge funds are buying Ginkgo Bioworks Holdings Inc. stock2025 Investor Takeaways & Technical Pattern Alert System - ulpravda.ru
Can Ginkgo Bioworks Holdings Inc. stock beat analyst upgradesPortfolio Gains Report & Growth Focused Entry Point Reports - ulpravda.ru
Is Ginkgo Bioworks Holdings Inc. stock overvalued by current metricsQuarterly Growth Report & Community Trade Idea Sharing - ulpravda.ru
Ginkgo Bioworks Holdings, Inc. (DNA) stock dips while market gains: Key facts - MSN
Can Ginkgo Bioworks Holdings Inc. Class stock surprise markets with earnings2025 Analyst Calls & Growth Focused Stock Pick Reports - ulpravda.ru
How rising interest rates impact Ginkgo Bioworks Holdings Inc. stock2025 Macro Impact & AI Enhanced Market Trend Forecasts - ulpravda.ru
Bull Bear: How Ginkgo Bioworks Holdings Inc. stock trades before earningsEarnings Trend Report & Weekly High Potential Alerts - ulpravda.ru
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - sharewise.com
Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weakness2025 Market Overview & Long-Term Investment Growth Plans - ulpravda.ru
Aug Gainers: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessInflation Watch & Safe Entry Momentum Tips - ulpravda.ru
How Ginkgo Bioworks Holdings Inc. Class stock reacts to Fed tighteningEarnings Performance Report & Fast Exit Strategy with Risk Control - ulpravda.ru
Analyst Downgrade: Can Ginkgo Bioworks Holdings Inc. stock rebound after recent weaknessTrend Reversal & Trade Opportunity Analysis Reports - ulpravda.ru
Ginkgo Bioworks realigns leadership, shifts COO responsibilities - MSN
Ginkgo Bioworks (DNA) Upgraded to Strong Buy: Here's What You Should Know - MSN
Ginkgo Bioworks announces COO transition and operational leadership changes By Investing.com - Investing.com Australia
Ginkgo Bioworks announces COO transition and operational leadership changes - Investing.com
Is Ginkgo Bioworks Holdings Inc a good long term investmentInsider Trading Compliance & Affordable Trading Techniques - earlytimes.in
Penny Stocks That Will Make You Richcareer Html Definition Characteristics & How To Invest - shababeek.org
Ginkgo Bioworks Holdings, Inc. (DNA) rises as market takes a dip: Key facts - MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Ginkgo Bioworks Holdings Insider Sellers Miss The Bus As Stock Jumps 10.0% - simplywall.st
Liquidity Mapping Around (DNA) Price Events - Stock Traders Daily
Ginkgo Bioworks announces operating leadership transition effective January 2026 - Investing.com India
Ginkgo Bioworks announces operating leadership transition effective January 2026 By Investing.com - Investing.com Australia
Ginkgo Bioworks Announces COO Transition - TradingView — Track All Markets
Ginkgo Bioworks shifts operating duties in leadership restructure - StreetInsider
Ginkgo Bioworks (NYSE: DNA) realigns leadership as Shetty refocuses on lab - Stock Titan
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach - Sahm
Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans - Sahm
Ginkgo Bioworks, Carnegie Mellon Partner on At-Home Cancer Detection Technology - marketscreener.com
Ginkgo Bioworks Partners with CMU to Develop Innovative Cancer Detection Technology - Intellectia AI
Ginkgo Bioworks partners with CMU on innovative cancer detection By Investing.com - Investing.com Canada
Ginkgo Bioworks (NYSE:DNA) Trading Up 10%Time to Buy? - MarketBeat
Will Ginkgo Bioworks Holdings Inc. stock recover faster than marketJuly 2025 Price Swings & Low Drawdown Trading Strategies - Улправда
Is Ginkgo Bioworks Holdings Inc. stock resilient to inflationEarnings Miss & Consistent Income Trade Ideas - DonanımHaber
Is Ginkgo Bioworks Holdings Inc. stock a contrarian buy2025 Price Momentum & Weekly Top Performers Watchlists - Улправда
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: A 29.45% Upside Amidst Biotech Challenges - DirectorsTalk Interviews
Will Ginkgo Bioworks Holdings Inc. stock maintain momentum in 20252025 Volatility Report & Safe Capital Allocation Plans - Улправда
Ginkgo Bioworks, Agricen Collaborate on Soil Amendment Fermentation - marketscreener.com
Ginkgo Bioworks and Agricen complete fermentation process optimization By Investing.com - Investing.com Canada
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment - Finviz
New partnership speeds up production of helpful soil bacteria for crops - Stock Titan
CFO Coen Acquires 750 Of Ginkgo Bioworks Holdings Inc [DNA] - TradingView — Track All Markets
Ginkgo Bioworks Holdings, Inc. (DNA) insider details RSU vesting and tax sale - Stock Titan
DNA (NYSE: DNA) holder plans sale of 736 Class A shares on NYSE per notice - Stock Titan
Price-Driven Insight from (DNA) for Rule-Based Strategy - Stock Traders Daily
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ginkgo Bioworks Holdings Inc-Aktie (DNA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Coen Steven P. | See remarks |
Dec 15 '25 |
Sale |
8.89 |
736 |
6,540 |
7,488 |
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):